Anti-IAV HA Recombinant Antibody (Navivumab) (CAT#: TAB-438CQ)

Recombinant monoclonal antibody to Influenza A virus HA. Navivumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza. It inhibits the entry of influenza virus into host cells by blocking HA-mediated membrane fusion.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG1, κ
  • Specificity
  • Influenza A virus hemagglutinin HA
  • Species Reactivity
  • Influenza A virus
  • Applications
  • Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Blocking
  • Conjugate
  • Unconjugated
  • CAS
  • 1443004-16-7
  • Generic Name
  • Navivumab
  • UNII
  • T03CDT3SDM
  • Related Disease
  • Influenza

Product Property

  • Purity
  • > 95% as determined by SDS-PAGE
  • Storage
  • Store at -20°C for long-term storage. Avoid freeze/thaw cycles.

Target

  • Alternative Names
  • Influenza A virus hemagglutinin; Influenza A virus HA

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Navivumab"

Afuco™ Anti-IAV HA ADCC Recombinant Antibody (Navivumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Influenza A virus HA. Navivumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza. It inhibits the entry of influenza virus into host cells by blocking HA-mediated membrane fusion.

See other products for "IAV HA"

Select a product category from the dropdown menu below to view related products.
Please select product type
Single-domain Antibody Human Antibody Recombinant Antibody Fab Fragment Antibody Epitope-Specific Antibody scFv Fragment Antibody ADCC Enhanced Antibody MHC Tetramer for Virology IgM Antibody Antibody Magnetic Beads

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAB-438CQ. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare